【中航证券】恩华药业（002262）-核心业务稳健增长，创新管线持续丰富-250406（4页）.pdf

1、 1 报表预测报表预测单位:百万元单位:百万元会计年度会计年度2022202220232023202420242025E2025E2026E2026E2027E2027E利润表利润表 营业收入4,298.515,041.505,697.636,506.807,539.378,543.82 减:营业成本1,020.461,369.841,506.541,712.331,937.602,168.19 税金及附加57.4668.0075.2986.91100.70114.12 主营业务利润 主营业务利润3,220.593,603.664,115.804,707.565,501.066,261.51

2、减:销售费用1,654.851,737.001,984.752,264.372,623.702,956.16 管理费用192.57207.12258.76292.81339.27384.47 研发费用454.25549.32595.65683.21791.63897.10 财务费用-20.78-19.26-17.13-5.43-10.88-16.48 经营性利润 经营性利润939.701,129.491,293.761,472.591,757.332,040.26 加:资产减值损失-16.19-33.27-39.07-37.35-43.28-49.05 信用减值损失-3.58-15.11-34

3、.57-21.47-24.88-28.19 其他经营损益-0.00 0.000.000.000.000.00 投资收益36.2751.0465.5750.9650.9650.96 公允价值变动损益0.000.000.000.000.000.00 资产处置收益0.370.150.290.270.270.27 其他收益46.9050.0550.5949.1849.1849.18 营业利润 营业利润1,003.471,182.341,336.571,514.181,789.592,063.43 加:其他非经营损益0.000.000.000.000.000.00 营业外收入2.536.754.654.

4、644.644.64 减:营业外支出16.0920.4544.5427.0227.0227.02 利润总额 利润总额989.911,168.641,296.691,491.801,767.202,041.05 减:所得税109.52134.40155.90171.99203.74235.31 净利润 净利润880.391,034.251,140.791,319.811,563.471,805.74 减:少数股东损益-20.54-2.67-2.77-12.47-14.77-17.06 归属母公司股东净利润 归属母公司股东净利润900.931,036.921,143.561,332.281,578

5、.241,822.80资产负债表资产负债表 货币资金1,532.212,158.951,416.392,636.644,001.565,535.97 交易性金融资产1,452.001,335.002,373.002,373.002,373.002,373.00 应收票据0.000.000.000.000.000.00 应收账款843.931,053.501,496.411,448.711,678.601,902.24 预付账款63.4036.6357.8469.7780.8491.61 其他应收款29.9322.4821.9233.1238.3843.49 存货716.34628.64661.

6、39913.191,033.331,156.30 其他流动资产12.5919.3632.5927.0931.3935.57 长期股权投资78.3872.5597.32108.82120.33131.83 金融资产投资40.2234.2227.9927.9927.9927.99 投资性房地产52.6350.5252.0445.1238.2131.30 固定资产和在建工程1,303.701,496.001,608.841,397.181,177.44949.62 无形资产和开发支出223.75276.16394.41351.22303.52251.31 其他